VL 285

Pricing Availability   Qty
说明: VHL inhibitor
化学名: (2S,4R)-4-Hydroxy-1-((S)-3-methyl-2-(1-oxoisoindolin-2-yl)butanoyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
纯度: ≥97% (HPLC)
说明书
引用文献
评论
文献 (3)

生物活性 for VL 285

VL 285 is an E3 ubiquitin ligase VHL inhibitor (IC50= 340 nM). VL 285 treatment competitively reduces or reverses target protein degradation by AU-15330 and HaloPROTAC3 Degraders.

技术数据 for VL 285

分子量 532.66
公式 C29H32N4O4S
储存 Store at -20°C
纯度 ≥97% (HPLC)
CAS Number 1448188-57-5
PubChem ID 71667162
InChI Key HEDFFPYRFJKXQP-VJTSUQJLSA-N
Smiles CC1=C(C2=CC=C(CNC([C@H]3N(C([C@@H](N4CC(C=CC=C5)=C5C4=O)C(C)C)=O)C[C@H](O)C3)=O)C=C2)SC=N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for VL 285

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 26.63 50
ethanol 10.65 20

制备储备液 for VL 285

以下数据基于产品分子量 532.66。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.5 mM 3.75 mL 18.77 mL 37.55 mL
2.5 mM 0.75 mL 3.75 mL 7.51 mL
5 mM 0.38 mL 1.88 mL 3.75 mL
25 mM 0.08 mL 0.38 mL 0.75 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for VL 285

参考文献是支持产品生物活性的出版物。

Buckley et al (2015) HaloPROTACS: use of small molecule PROTACs to induce degradation of HaloTag fusion proteins. ACS Chem.Biol. 10 1831 PMID: 26070106

Xiao et al (2022) Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature 601 434 PMID: 34937944


If you know of a relevant reference for VL 285, please let us know.

按产品操作查看相关产品

查看全部 Ubiquitin E3 Ligase Inhibitors

关键词: VL 285, VL 285 supplier, VL285, von, hippel, lindau, ligand, E3, ubiquitin, ligase, inhibitor, inhibitors, inhibits, VHL, degradation, Ubiquitin, Ligases, 7903, Tocris Bioscience

篇 VL 285 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 VL 285 的引用文献。 您是否知道使用了 Tocris VL 285 的优秀论文? 请告知我们.

VL 285 的评论

目前没有该产品的评论。 Be the first to review VL 285 and earn rewards!

Have you used VL 285?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


TPD and Induced Proximity Research Product Guide

TPD and Induced Proximity Research Product Guide

This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:

  • Active Degraders
  • TAG Degradation Platform
  • Degrader Building Blocks
  • Assays for Protein Degradation
  • Induced Proximity Tools
Programmed Cell Death Poster

Programmed Cell Death Poster

There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.

Targeted Protein Degradation Poster

Targeted Protein Degradation Poster

Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia